What are the effects of buprenorphine transdermal delivery system (BTDS) for the treatment of chronic pain syndrome (CPS)?

Updated: Jan 14, 2020
  • Author: Manish K Singh, MD; Chief Editor: Stephen Kishner, MD, MHA  more...
  • Print

A study by Gianni et al looked at the buprenorphine transdermal delivery system (BTDS) for its effect on chronic, noncancer pain. While the specific aim of this study was to examine cognitive and functional scores in an elderly population treated with the BTDS, a secondary finding related to its use was the effective analgesic activity and safety of BTDS in elderly patients. There was an improvement in mood and a partial resumption of activities, with no influence on cognitive and behavioral ability. [40]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!